India approves Saragene COVID-19 2-gene multiplex RT-PCR test

pharmanewsdaily- November 26, 2020 0

CoSara Diagnostics has secured clearance from the Indian Central Drugs Standard Control Organization (CDSCO) to manufacture and sell its Saragene COVID-19 2-gene multiplex RT-PCR test. ... Read More

BNT162b2 Covid-19 vaccine candidate more than 90% effective in phase 3 trial, say Pfizer and BioNTech

pharmanewsdaily- November 10, 2020 0

Pfizer and BioNTech announced that the BNT162b2 mRNA-based vaccine candidate has been shown to be more than 90% effective in the prevention of Covid-19 in ... Read More

AstraZeneca to advance AZD7442 into phase 3 Covid-19 trials

pharmanewsdaily- October 11, 2020 0

AstraZeneca said that AZD7442, which is being developed for the prevention and treatment of Covid-19, will move into two phase 3 clinical trials. AZD7442 is ... Read More

Novavax begins phase 3 trial of NVX-CoV2373 COVID-19 vaccine candidate

pharmanewsdaily- September 25, 2020 0

Novavax has initiated its first phase 3 clinical trial to assess the efficacy, safety, and immunogenicity of its NVX-CoV2373 COVID-19 vaccine candidate. The US vaccine ... Read More

Janssen Covid-19 vaccine candidate Ad26.COV2.S bags $1bn deal from US govt

pharmanewsdaily- August 5, 2020 0

Johnson & Johnson (J&J) said that its subsidiary Janssen Pharmaceutical has agreed to manufacture and supply 100 million doses of its SARS-CoV-2 investigational vaccine Ad26.COV2.S ... Read More

Novavax NVX-CoV2373 COVID-19 vaccine candidate to be manufactured by FDB

pharmanewsdaily- July 24, 2020 0

Novavax has signed an agreement with FUJIFILM Diosynth Biotechnologies (FDB), a US-based contract development and manufacturing organization (CDMO), for the manufacturing of bulk drug substance ... Read More

BNT162 COVID-19 vaccine candidate : US govt signs $2bn supply deal with Pfizer and BioNTech

pharmanewsdaily- July 22, 2020 0

Pfizer and BioNTech have bagged a $1.95 billion deal with the US government for supplying 100 million doses of their jointly developed BNT162 COVID-19 vaccine ... Read More

COV001 clinical trial results : Oxford vaccine ChAdOx1 nCoV-19 triggers strong immune response

pharmanewsdaily- July 20, 2020 0

COV001 clinical trial results : AstraZeneca and Oxford University said that interim results from the phase 1/2 COV001 clinical trial showed the ChAdOx1 nCoV-19 vaccine ... Read More

BNT162b1 and BNT162b2 Covid-19 vaccine candidates get FDA fast track status

pharmanewsdaily- July 14, 2020 0

Pfizer and BioNTech said that BNT162b1 and BNT162b2, two vaccine candidates developed to give protection against the SARS-CoV-2 virus have been given the fast track ... Read More

Gilead Sciences announces Veklury EU approval for COVID-19 treatment

pharmanewsdaily- July 6, 2020 0

Veklury EU approval : Gilead Sciences said that Veklury (remdesivir) has been given conditional marketing authorization from the European Commission as a treatment for SARS-CoV-2 ... Read More